# Graham Corp: financial statements, quarterly

GHM · NYSE · CIK 716314 · [Industrials](/sectors/industrials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/ghm.md) · [Financials](/companies/ghm/financials.md) · [Filings](/companies/ghm/filings.md) · [Insiders](/companies/ghm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ghm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q3 FY2023 (2023-12-31) | Q4 FY2023 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q3 FY2024 (2024-12-31) | Q4 FY2024 (2025-03-31) | Q1 FY2025 (2025-06-30) | Q2 FY2025 (2025-09-30) | Q3 FY2025 (2025-12-31) | Q4 FY2025 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [45.1](/filings/0000950170-24-123710.md) | [43.8](/filings/0000950170-25-015879.md) | [49.1 d](/filings/0001193125-26-260688.md) | [50.0](/filings/0000950170-25-102424.md) | [53.6](/filings/0001193125-25-271134.md) | [47.0](/filings/0001193125-26-040310.md) | [59.3 d](/filings/0001193125-26-260688.md) | [55.5](/filings/0001193125-26-336752.md) | [66.0](/filings/0001193125-25-271134.md) | [56.7](/filings/0001193125-26-040310.md) | [67.1 d](/filings/0001193125-26-260688.md) | [71.3](/filings/0001193125-26-336752.md) |
| Cost of revenue | $m | [37.9](/filings/0000950170-24-123710.md) | [34.1](/filings/0000950170-25-015879.md) | [36.4 d](/filings/0001193125-26-260688.md) | [37.6](/filings/0000950170-25-102424.md) | [40.8](/filings/0001193125-25-271134.md) | [35.4](/filings/0001193125-26-040310.md) | [43.3 d](/filings/0001193125-26-260688.md) | [40.8](/filings/0001193125-26-336752.md) | [51.7](/filings/0001193125-25-271134.md) | [43.2](/filings/0001193125-26-040310.md) | [51.8 d](/filings/0001193125-26-260688.md) | [53.5](/filings/0001193125-26-336752.md) |
| Gross profit | $m | [7.2](/filings/0000950170-24-123710.md) | [9.7](/filings/0000950170-25-015879.md) | [12.7 d](/filings/0001193125-26-260688.md) | [12.4](/filings/0000950170-25-102424.md) | [12.8](/filings/0001193125-25-271134.md) | [11.7](/filings/0001193125-26-040310.md) | [16.0 d](/filings/0001193125-26-260688.md) | [14.7](/filings/0001193125-26-336752.md) | [14.3](/filings/0001193125-25-271134.md) | [13.5](/filings/0001193125-26-040310.md) | [15.3 d](/filings/0001193125-26-260688.md) | [17.8](/filings/0001193125-26-336752.md) |
| Selling, general and administrative | $m | [6.1](/filings/0000950170-24-123710.md) | [8.4](/filings/0000950170-25-015879.md) | [10.7 d](/filings/0001193125-26-260688.md) | [8.8](/filings/0000950170-25-102424.md) | [8.7](/filings/0001193125-25-271134.md) | [9.3](/filings/0001193125-26-040310.md) | [10.3 d](/filings/0001193125-26-260688.md) | [9.4](/filings/0001193125-26-336752.md) | [9.8](/filings/0001193125-25-271134.md) | [10.1](/filings/0001193125-26-040310.md) | [12.2 d](/filings/0001193125-26-260688.md) | [12.6](/filings/0001193125-26-336752.md) |
| Operating income | $m | [0.8](/filings/0000950170-24-123710.md) | [0.9](/filings/0000950170-25-015879.md) | [1.5 d](/filings/0001193125-26-260688.md) | [3.2](/filings/0000950170-25-102424.md) | [4.2](/filings/0001193125-25-271134.md) | [2.2](/filings/0001193125-26-040310.md) | [5.5 d](/filings/0001193125-26-260688.md) | [5.0](/filings/0001193125-26-336752.md) | [4.3](/filings/0001193125-25-271134.md) | [3.1](/filings/0001193125-26-040310.md) | [2.7 d](/filings/0001193125-26-260688.md) | [4.2](/filings/0001193125-26-336752.md) |
| Interest expense | $m | [0.1](/filings/0000950170-23-059030.md) | [0.0](/filings/0000950170-24-011023.md) | [(0.0) d](/filings/0001193125-26-260688.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2](/filings/0000950170-24-123710.md) | [(0.1)](/filings/0000950170-25-015879.md) | [0.1 d](/filings/0001193125-26-260688.md) | [0.3](/filings/0000950170-25-102424.md) | [1.0](/filings/0001193125-25-271134.md) | [0.7](/filings/0001193125-26-040310.md) | [1.2 d](/filings/0001193125-26-260688.md) | [0.4](/filings/0001193125-26-336752.md) | [1.1](/filings/0001193125-25-271134.md) | [0.4](/filings/0001193125-26-040310.md) | [0.4 d](/filings/0001193125-26-260688.md) | [0.3](/filings/0001193125-26-336752.md) |
| Net income | $m | [0.4](/filings/0000950170-24-123710.md) | [0.2](/filings/0000950170-25-015879.md) | [1.3 d](/filings/0001193125-26-260688.md) | [3.0](/filings/0000950170-25-102424.md) | [3.3](/filings/0001193125-25-271134.md) | [1.6](/filings/0001193125-26-040310.md) | [4.4 d](/filings/0001193125-26-260688.md) | [4.6](/filings/0001193125-26-336752.md) | [3.1](/filings/0001193125-25-271134.md) | [2.8](/filings/0001193125-26-040310.md) | [2.0 d](/filings/0001193125-26-260688.md) | [3.9](/filings/0001193125-26-336752.md) |
| Diluted EPS | $ per share | [0.04](/filings/0000950170-24-123710.md) | [0.02](/filings/0000950170-25-015879.md) | not reported | [0.27](/filings/0000950170-25-102424.md) | [0.30](/filings/0001193125-25-271134.md) | [0.14](/filings/0001193125-26-040310.md) | not reported | [0.42](/filings/0001193125-26-336752.md) | [0.28](/filings/0001193125-25-271134.md) | [0.25](/filings/0001193125-26-040310.md) | not reported | [0.33](/filings/0001193125-26-336752.md) |
| Basic EPS | $ per share | [0.04](/filings/0000950170-24-123710.md) | [0.02](/filings/0000950170-25-015879.md) | not reported | [0.27](/filings/0000950170-25-102424.md) | [0.30](/filings/0001193125-25-271134.md) | [0.15](/filings/0001193125-26-040310.md) | not reported | [0.42](/filings/0001193125-26-336752.md) | [0.28](/filings/0001193125-25-271134.md) | [0.26](/filings/0001193125-26-040310.md) | not reported | [0.34](/filings/0001193125-26-336752.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q3 FY2023 (2023-12-31) | FY2023 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q3 FY2024 (2024-12-31) | FY2024 (2025-03-31) | Q1 FY2025 (2025-06-30) | Q2 FY2025 (2025-09-30) | Q3 FY2025 (2025-12-31) | FY2025 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.8](/filings/0000950170-23-059030.md) | [15.2](/filings/0000950170-24-011023.md) | [16.9](/filings/0000950170-25-083450.md) | [21.6](/filings/0000950170-24-092280.md) | [32.3](/filings/0000950170-24-123710.md) | [30.0](/filings/0000950170-25-015879.md) | [21.6](/filings/0001193125-26-260688.md) | [10.8](/filings/0000950170-25-102424.md) | [20.6](/filings/0001193125-25-271134.md) | [22.3](/filings/0001193125-26-040310.md) | [6.6](/filings/0001193125-26-336752.md) | [27.0](/filings/0001193125-26-336752.md) |
| Current assets | $m | [120](/filings/0000950170-23-059030.md) | [115](/filings/0000950170-24-011023.md) | [126](/filings/0000950170-25-083450.md) | [135](/filings/0000950170-24-092280.md) | [138](/filings/0000950170-24-123710.md) | [146](/filings/0000950170-25-015879.md) | [141](/filings/0001193125-26-260688.md) | [128](/filings/0000950170-25-102424.md) | [159](/filings/0001193125-25-271134.md) | [164](/filings/0001193125-26-040310.md) | [156](/filings/0001193125-26-336752.md) | [198](/filings/0001193125-26-336752.md) |
| Total assets | $m | [213](/filings/0000950170-23-059030.md) | [219](/filings/0000950170-24-011023.md) | [234](/filings/0000950170-25-083450.md) | [244](/filings/0000950170-24-092280.md) | [250](/filings/0000950170-24-123710.md) | [264](/filings/0000950170-25-015879.md) | [264](/filings/0001193125-26-260688.md) | [252](/filings/0000950170-25-102424.md) | [287](/filings/0001193125-25-271134.md) | [293](/filings/0001193125-26-040310.md) | [324](/filings/0001193125-26-336752.md) | [364](/filings/0001193125-26-336752.md) |
| Current liabilities | $m | [93.8](/filings/0000950170-23-059030.md) | [104](/filings/0000950170-24-011023.md) | [118](/filings/0000950170-25-083450.md) | [126](/filings/0000950170-24-092280.md) | [128](/filings/0000950170-24-123710.md) | [141](/filings/0000950170-25-015879.md) | [136](/filings/0001193125-26-260688.md) | [121](/filings/0000950170-25-102424.md) | [152](/filings/0001193125-25-271134.md) | [155](/filings/0001193125-26-040310.md) | [156](/filings/0001193125-26-336752.md) | [161](/filings/0001193125-26-336752.md) |
| Total liabilities | $m | [112](/filings/0000950170-23-059030.md) | [115](/filings/0000950170-24-011023.md) | [128](/filings/0000950170-25-083450.md) | [136](/filings/0000950170-24-092280.md) | [137](/filings/0000950170-24-123710.md) | [150](/filings/0000950170-25-015879.md) | [145](/filings/0001193125-26-260688.md) | [129](/filings/0000950170-25-102424.md) | [159](/filings/0001193125-25-271134.md) | [162](/filings/0001193125-26-040310.md) | [183](/filings/0001193125-26-336752.md) | [172](/filings/0001193125-26-336752.md) |
| Long-term debt | $m | [11.5](/filings/0000950170-23-059030.md) | [0.0](/filings/0000950170-24-011023.md) | [0.0](/filings/0000950170-24-070222.md) | not reported | not reported | not reported | [0.0](/filings/0001193125-26-260688.md) | not reported | not reported | not reported | [13.0](/filings/0001193125-26-336752.md) | [0.0](/filings/0001193125-26-336752.md) |
| Current portion of debt | $m | [2.0](/filings/0000950170-23-059030.md) | [0.0](/filings/0000950170-24-011023.md) | [0.0](/filings/0000950170-24-070222.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [3.0](/filings/0000950170-24-011023.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [101](/filings/0000950170-25-015879.md) | [104](/filings/0000950170-25-015879.md) | [106](/filings/0001193125-26-260688.md) | [108](/filings/0001193125-26-040310.md) | [112](/filings/0001193125-26-040310.md) | [114](/filings/0001193125-26-040310.md) | [120](/filings/0001193125-26-336752.md) | [123](/filings/0001193125-26-336752.md) | [128](/filings/0001193125-26-040310.md) | [131](/filings/0001193125-26-040310.md) | [140](/filings/0001193125-26-336752.md) | [192](/filings/0001193125-26-336752.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q3 FY2023 (2023-12-31) | Q4 FY2023 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q3 FY2024 (2024-12-31) | Q4 FY2024 (2025-03-31) | Q1 FY2025 (2025-06-30) | Q2 FY2025 (2025-09-30) | Q3 FY2025 (2025-12-31) | Q4 FY2025 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.3 d](/filings/0000950170-24-123710.md) | [7.6 d](/filings/0000950170-25-015879.md) | [8.6 d](/filings/0001193125-26-260688.md) | [8.7](/filings/0000950170-25-102424.md) | [13.9 d](/filings/0001193125-25-271134.md) | [5.2 d](/filings/0001193125-26-040310.md) | [(3.6) d](/filings/0001193125-26-260688.md) | [(2.3)](/filings/0001193125-26-336752.md) | [13.6 d](/filings/0001193125-25-271134.md) | [4.8 d](/filings/0001193125-26-040310.md) | [(0.2) d](/filings/0001193125-26-260688.md) | [(12.7)](/filings/0001193125-26-336752.md) |
| Capital expenditure | $m | [1.8 d](/filings/0000950170-24-123710.md) | [1.9 d](/filings/0000950170-25-015879.md) | [4.0 d](/filings/0001193125-26-260688.md) | [3.0](/filings/0000950170-25-102424.md) | [3.5 d](/filings/0001193125-25-271134.md) | [7.3 d](/filings/0001193125-26-040310.md) | [5.2 d](/filings/0001193125-26-260688.md) | [7.0](/filings/0001193125-26-336752.md) | [4.1 d](/filings/0001193125-25-271134.md) | [2.3 d](/filings/0001193125-26-040310.md) | [2.6 d](/filings/0001193125-26-260688.md) | [2.6](/filings/0001193125-26-336752.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-123710.md) | [0.0 d](/filings/0000950170-25-015879.md) | [0.0 d](/filings/0000950170-25-083450.md) | [0.8](/filings/0000950170-24-092280.md) | [0.0 d](/filings/0000950170-24-123710.md) | [0.0 d](/filings/0000950170-25-015879.md) | [0.0 d](/filings/0000950170-25-083450.md) | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-09-30) | Q3 FY2022 (2022-12-31) | Q1 FY2023 (2023-06-30) | Q2 FY2023 (2023-09-30) | Q3 FY2023 (2023-12-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q3 FY2024 (2024-12-31) | Q1 FY2025 (2025-06-30) | Q2 FY2025 (2025-09-30) | Q3 FY2025 (2025-12-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.6](/filings/0000950170-23-059030.md) | [10.7](/filings/0000950170-24-011023.md) | [10.7](/filings/0000950170-24-092280.md) | [10.8](/filings/0000950170-24-123710.md) | [10.9](/filings/0000950170-25-015879.md) | [11.0](/filings/0000950170-25-102424.md) | [11.0](/filings/0001193125-25-271134.md) | [11.1](/filings/0001193125-26-040310.md) | [11.0](/filings/0001193125-26-336752.md) | [11.1](/filings/0001193125-25-271134.md) | [11.2](/filings/0001193125-26-040310.md) | [11.7](/filings/0001193125-26-336752.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,737,033 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-336752.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.